IBLHL Medical Distributors
Distribution Services
41.12 +0.22%
Mkt Cap
4.0B
P/E (TTM)
18.34
EPS (TTM)
2.24
ROE (TTM)
9.06%
Div Yield
—
IBL HealthCare Limited (IBLHL) Financial Statements, Ratios & Dividends
About
IBL Healthcare Ltd. engages in marketing, selling and distribution of healthcare products. The company operates a distribution warehouse in Sindh Industrial Trading Estate. IBL Healthcare was founded on July 14, 1997 and is headquartered in Karachi, Pakistan.
Financial Highlights
| FY2026 | FY2025 | ||
|---|---|---|---|
| Revenue | 4.61B | 4.32B | |
| Gross Profit | 1.63B | 1.44B | |
| Net Income | 220.40M | 208.37M | |
| EPS | 2.24 | 2.11 | |
| ROE | 9.06% | 9.39% | |
| ROA | 5.48% | 5.68% | |
| Gross Margin | 35.46% | 33.29% | |
| Net Margin | 4.78% | 4.82% | |
| Current Ratio | 2.30 | 2.02 | |
| DPS | 0.00 | 0.00 | |
| Free Cash Flow | 653.31M | -278.81M |
| FY2026 | FY2025 | ||
|---|---|---|---|
| Total Revenue | 4.61B | 4.32B | |
| Cost of Goods Sold | -2.97B | -2.88B | |
| Gross Profit | 1.63B | 1.44B | |
| SG&A Expenses | -1.13B | -970.20M | |
| Depreciation | -10.20M | -7.34M | |
| Other Operating Expense | -53.96M | -53.23M | |
| Total Operating Expense | -4.16B | -3.91B | |
| Operating Income (EBIT) | 449.19M | 415.34M | |
| Interest Income | 0 | 0 | |
| Interest Expense | -42.87M | -60.21M | |
| Equity in Earnings | 0 | 0 | |
| Other Non-Operating Income | -5.07M | -14.92M | |
| Total Non-Operating Income | -47.94M | -75.13M | |
| Pre-Tax Income | 401.26M | 340.21M | |
| Income Tax | -180.85M | -131.84M | |
| Minority Interest | 0 | 0 | |
| Net Income | 220.40M | 208.37M | |
| EBITDA | 460.13M | 423.54M | |
| EPS (Basic) | 2.24 | 2.11 | |
| EPS (Diluted) | 2.24 | 2.11 | |
| Gross Margin | 35.46% | 33.29% | |
| Operating Margin | 9.75% | 9.61% | |
| EBITDA Margin | 9.99% | 9.80% | |
| Pre-Tax Margin | 8.71% | 7.87% | |
| Net Margin | 4.78% | 4.82% |
| FY2026 | FY2025 | ||
|---|---|---|---|
| Profitability | |||
| Return on Equity (ROE) | 9.06% | 9.39% | |
| Return on Assets (ROA) | 5.48% | 5.68% | |
| Return on Invested Capital | 8.99% | 9.35% | |
| Gross Margin | 35.46% | 33.29% | |
| Operating Margin | 9.75% | 9.61% | |
| EBITDA Margin | 9.99% | 9.80% | |
| Net Margin | 4.78% | 4.82% | |
| Pre-Tax Margin | 8.71% | 7.87% | |
| Liquidity | |||
| Current Ratio | 2.30 | 2.02 | |
| Quick Ratio | 1.60 | 1.25 | |
| Leverage | |||
| Debt / Equity | 0.01 | 0.07 | |
| Debt / Assets | 0.01 | 0.04 | |
| LT Debt / Equity | 0.01 | 0.01 | |
| LT Debt / Assets | 0.00 | 0.00 | |
| Net Debt | -700.60M | -49.96M | |
| Total Debt | 26.59M | 158.98M | |
| Efficiency | |||
| Asset Turnover | 1.15 | 1.18 | |
| Inventory Turnover | 2.56 | 2.62 | |
| Per Share | |||
| Book Value Per Share | 25.82 | 23.58 | |
| Tangible Book Per Share | 25.81 | 23.56 | |
| Cash Per Share | 7.38 | 2.12 | |
| Total Debt Per Share | 0.27 | 1.61 | |
| Working Capital Per Share | 19.49 | 17.27 | |
| Shares & Market | |||
| Total Shares Outstanding | 98,525,979 | 98,526,004 | |
| Market Cap | 5.22B | 5.36B | |
| Enterprise Value | 4.52B | 5.31B | |
| Employees | 208 | 224 | |
| Shareholders | 7,007 | 7,007 | |
| FY2026 | FY2025 | ||
|---|---|---|---|
| Dividends Per Share | 0.00 | 0.00 | |
| Dividend Yield | 0.00% | 0.00% | |
| Payout Ratio | 0.00% | 0.00% | |
| Total Dividends Paid | -20.0K | -176.0K |
| FY2026 | FY2025 | ||
|---|---|---|---|
| P/E Ratio | 23.70 | 25.74 | |
| P/B Ratio | 2.05 | 2.31 | |
| P/S Ratio | 1.13 | 1.24 | |
| P/CF Ratio | 7.92 | — | |
| EV/EBITDA | 9.83 | 12.54 | |
| Market Cap | 5.22B | 5.36B | |
| Enterprise Value | 4.52B | 5.31B |
| TTM | ||
|---|---|---|
| Income | ||
| Revenue | 4.61B | |
| Gross Profit | 1.63B | |
| Operating Income | 433.10M | |
| Net Income | 220.40M | |
| EBIT | 433.10M | |
| Free Cash Flow | 653.31M | |
| EPS (Basic) | 2.24 | |
| Margins | ||
| Gross Margin | 35.46% | |
| Operating Margin | 9.40% | |
| Net Margin | 4.78% | |
| Returns | ||
| Return on Equity (ROE) | 9.06% | |
| ROIC | 0.09% | |
| Coverage & Debt | ||
| Interest Coverage | 10.1x | |
| Dividend Coverage | 11198.85 | |
| Debt / Revenue | 0.01 | |
| Valuation & Scores | ||
| P/E (TTM) | 18.34 | |
| Sloan Ratio | -10.73 | |
| Zmijewski Score | -2.47 | |
Computed Metrics (Latest Period)
| FY2026 | ||
|---|---|---|
| Extended Returns | ||
| Return on Common Equity | 9.06% | |
| Return on Tangible Equity | 9.06% | |
| Return on Tangible Assets | 5.48% | |
| Return on Total Capital | 17.78% | |
| ROCE | 18.33% | |
| Growth | ||
| EPS Diluted Growth | 0.06% | |
| Sustainable Growth Rate | 9.06% | |
| Quality & Risk Scores | ||
| Piotroski F-Score | 7 | |
| Zmijewski Score | -2.47 | |
| Sloan Ratio | -10.73 | |
| Valuation (Computed) | ||
| Graham Number | 36.05 | |
| Tobin's Q Ratio | 1.29 | |
| Leverage & Coverage | ||
| Interest Coverage | 10.5x | |
| Total Debt / Capital | 0.01% | |
| Assets / Equity (Leverage) | 1.59 | |
| Net Debt / EBITDA | -1.52 | |
| Effective Interest Rate | 46.20% | |
| Debt / Revenue | 0.01 | |
| Efficiency (Computed) | ||
| Fixed Asset Turnover | 115.42 | |
| Receivables Turnover | 2.80 | |
| Dividends (Computed) | ||
| Payout Ratio | 0.00% | |
| Dividend Coverage | 11198.85 | |
| Share Buyback Ratio | 0.00 | |
| Per Employee | ||
| Revenue / Employee | 22.15M | |
| Net Income / Employee | 1.06M | |
| Oper. Income / Employee | 2.16M | |
| Total Assets / Employee | 19.40M | |
| Balance Sheet (Computed) | ||
| Tangible Assets | 4.03B | |
| Invested Capital | 2.56B | |
| Working Capital | 1.92B | |
| Book Value Per Share | 25.82 | |
| Earnings Schedule | ||